Aspyra Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a APYI research report →
Companywww.aspyra.com
Aspyra Inc. provides health care products and services for the laboratory and imaging marketplaces. It offers engineered workflow solutions that include software, interfaces, hardware, and professional services to various markets comprising specialty labs, reference labs, clinics, hospitals, imaging centers, and orthopedic practices.
- CEO
- Gary W. Bennett
- IPO
- 1983
- Employees
- 69
- HQ
- Jacksonville, FL, US
Price Chart
Valuation
- Market Cap
- $34
- P/E
- -0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -1.39
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 45.94%
- Op Margin
- 55.16%
- Net Margin
- -60.87%
- ROE
- -59.98%
- ROIC
- 45.24%
Growth & Income
- Revenue
- $8.53M · -17.00%
- Net Income
- $-5,189,900 · -23.07%
- EPS
- $-42.15 · -12.19%
- Op Income
- $4.70M
- FCF YoY
- 11.80%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -51.48
- Avg Volume
- 67.456
Get TickerSpark's AI analysis on APYI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our APYI Coverage
We haven't published any research on APYI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate APYI Report →